Literature DB >> 21309674

Celiac disease and health-related quality of life.

Kalle Kurppa1, Pekka Collin, Markku Mäki, Katri Kaukinen.   

Abstract

Celiac disease is a particularly common life-long disorder with a prevalence of approximately 1-2% in Western populations. In recent years the health-related quality of life has become an important issue in this context, and most studies carried out so far have shown diminished quality of life in untreated patients compared with healthy controls. Furthermore, there has generally been a beneficial response to treatment with a gluten-free diet. However, the majority of trials have been carried out among adults with gastrointestinal disease, while in fact several extraintestinal and atypical forms of celiac disease might be even more common than the classical disorder. In addition, only a small proportion of these studies have been conducted among children. This article highlights the studies of health-related quality of life and celiac disease conducted to date. Particular attention is paid to the extraintestinal and atypical forms of the disorder.

Entities:  

Mesh:

Year:  2011        PMID: 21309674     DOI: 10.1586/egh.10.81

Source DB:  PubMed          Journal:  Expert Rev Gastroenterol Hepatol        ISSN: 1747-4124            Impact factor:   3.869


  20 in total

1.  Caring for a Celiac Partner: Gluten, but not Worry Free.

Authors:  Prashant Singh
Journal:  Dig Dis Sci       Date:  2016-12       Impact factor: 3.199

2.  Health-related quality of life in children and adolescents with celiac disease: patient-driven data from focus group interviews.

Authors:  Halfdan Skjerning; Ruth O Mahony; Steffen Husby; Audrey DunnGalvin
Journal:  Qual Life Res       Date:  2014-01-21       Impact factor: 4.147

Review 3.  Psychological morbidity of celiac disease: A review of the literature.

Authors:  Fabiana Zingone; Gillian L Swift; Timothy R Card; David S Sanders; Jonas F Ludvigsson; Julio C Bai
Journal:  United European Gastroenterol J       Date:  2015-04       Impact factor: 4.623

4.  A comprehensive questionnaire for the assessment of health-related quality of life in coeliac disease (CDQL).

Authors:  Halfdan Skjerning; Jonathan Hourihane; Steffen Husby; Audrey DunnGalvin
Journal:  Qual Life Res       Date:  2017-07-05       Impact factor: 4.147

5.  Evaluating Responses to Gluten Challenge: A Randomized, Double-Blind, 2-Dose Gluten Challenge Trial.

Authors:  Maureen M Leonard; Jocelyn A Silvester; Daniel Leffler; Alessio Fasano; Ciarán P Kelly; Suzanne K Lewis; Jeffrey D Goldsmith; Elliot Greenblatt; William W Kwok; William J McAuliffe; Kevin Galinsky; Jenifer Siegelman; I-Ting Chow; John A Wagner; Anna Sapone; Glennda Smithson
Journal:  Gastroenterology       Date:  2020-10-29       Impact factor: 22.682

6.  Pancrelipase: an evidence-based review of its use for treating pancreatic exocrine insufficiency.

Authors:  Kei Nakajima; Haruki Oshida; Toshitaka Muneyuki; Masafumi Kakei
Journal:  Core Evid       Date:  2012-07-19

7.  Validation of the Turkish version of the Celiac Disease Questionnaire (CDQ).

Authors:  Ayşegül Aksan; Seyit Mehmet Mercanlıgil; Winfried Häuser; Eda Karaismailoğlu
Journal:  Health Qual Life Outcomes       Date:  2015-06-19       Impact factor: 3.186

8.  Parenting stress and impact of illness in parents of children with coeliac disease.

Authors:  Maria Stella Epifanio; Vitalba Genna; Maria Grazia Vitello; Michele Roccella; Sabina La Grutta
Journal:  Pediatr Rep       Date:  2013-12-19

9.  Clinical Characteristics of Celiac Disease and Dietary Adherence to Gluten-Free Diet among Saudi Children.

Authors:  Ahmed Al Sarkhy; Mohammad I El Mouzan; Elshazaly Saeed; Aziz Alanazi; Sharifa Alghamdi; Shirin Anil; Asaad Assiri
Journal:  Pediatr Gastroenterol Hepatol Nutr       Date:  2015-03-30

10.  Predictors of persistent symptoms and reduced quality of life in treated coeliac disease patients: a large cross-sectional study.

Authors:  Pilvi Paarlahti; Kalle Kurppa; Anniina Ukkola; Pekka Collin; Heini Huhtala; Markku Mäki; Katri Kaukinen
Journal:  BMC Gastroenterol       Date:  2013-04-30       Impact factor: 3.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.